Loading…

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22

Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisation peak by 25%, 36% and 43% respectively, with a delay...

Full description

Saved in:

Bibliographic Details
Published in:	Euro surveillance : bulletin européen sur les maladies transmissibles 2022-01, Vol.27 (1)
Main Authors:	Bosetti, Paolo, Tran Kiem, Cécile, Andronico, Alessio, Paireau, Juliette, Levy-Bruhl, Daniel, Alter, Lise, Fontanet, Arnaud, Cauchemez, Simon
Format:	Article
Language:	English
Subjects:	COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage Disease control France - epidemiology Hospitalization Human health and pathology Humans Immunity (Disease) Immunization, Secondary Infectious diseases Life Sciences Mathematical models Rapid Communication Santé publique et épidémiologie SARS-CoV-2 Seasons Vaccination
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3
cites	cdi_FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3
container_end_page
container_issue	1
container_start_page
container_title	Euro surveillance : bulletin européen sur les maladies transmissibles
container_volume	27
creator	Bosetti, Paolo Tran Kiem, Cécile Andronico, Alessio Paireau, Juliette Levy-Bruhl, Daniel Alter, Lise Fontanet, Arnaud Cauchemez, Simon
description	Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisation peak by 25%, 36% and 43% respectively, with a delay of 5 months between second and third dose. A 10% reduction in transmission rates might further reduce it by 41%, indicating that even small increases in protective behaviours may be critical to mitigate the wave.
doi_str_mv	10.2807/1560-7917.ES.2022.27.1.2101125
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8739339</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618230021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3</originalsourceid><addsrcrecordid>eNpdUl1v0zAUtRCIjcJfQJaQEDwku77Ol3lAmrqOVaq0hwGvlmuc1VNih8Rp2d_gF-PQ0o1Jlmxdn3Pu1yHkPYMUKyjPWF5AUgpWpoubFAExxTJlKTJgDPNn5PQIeP7ofUJeDcMdQMZB4EtywjMRo2V1Sn4v207pQH1N194PwfR0q7S2TgXrHY0nbAzV3oXeNxNqfv19eZEwQS9MExTdqa2h9gFlfv3V2iln3S21bTs6G-4_UdV1jdV70eDpZa-cPhJ31k2JYzvsDPE1eVGrZjBvDveMfLtcfJ1fJavrL8v5-SrROUBIBIqszrk2WPAC1pVgBn5ow7MamcgVL2oNOUeEsjZFkWGt1qwuAIwoMBOl4TPyea_bjevWRGrsUTWy622r-nvplZX__zi7kbd-K6uSCx7PjHzcC2ye0K7OV3KKAc9ZJUrYsoj9cEjW-5-jGYJs7aBN0yhn_DhILFiFHOIEIvTdE-idH3sXRxFRCBB3yLOH6nXvh6E39bECBnKyipy2L6fty8WNnKwiMQblwSpR4O3j9o_0f97gfwCCAblG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620030934</pqid></control><display><type>article</type><title>Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22</title><source>PubMed Central</source><creator>Bosetti, Paolo ; Tran Kiem, Cécile ; Andronico, Alessio ; Paireau, Juliette ; Levy-Bruhl, Daniel ; Alter, Lise ; Fontanet, Arnaud ; Cauchemez, Simon</creator><creatorcontrib>Bosetti, Paolo ; Tran Kiem, Cécile ; Andronico, Alessio ; Paireau, Juliette ; Levy-Bruhl, Daniel ; Alter, Lise ; Fontanet, Arnaud ; Cauchemez, Simon</creatorcontrib><description>Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisation peak by 25%, 36% and 43% respectively, with a delay of 5 months between second and third dose. A 10% reduction in transmission rates might further reduce it by 41%, indicating that even small increases in protective behaviours may be critical to mitigate the wave.</description><identifier>ISSN: 1560-7917</identifier><identifier>ISSN: 1025-496X</identifier><identifier>EISSN: 1560-7917</identifier><identifier>EISSN: 1025-496X</identifier><identifier>DOI: 10.2807/1560-7917.ES.2022.27.1.2101125</identifier><identifier>PMID: 34991778</identifier><language>eng</language><publisher>Sweden: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</publisher><subject>COVID-19 ; COVID-19 - prevention & control ; COVID-19 vaccines ; COVID-19 Vaccines - administration & dosage ; Disease control ; France - epidemiology ; Hospitalization ; Human health and pathology ; Humans ; Immunity (Disease) ; Immunization, Secondary ; Infectious diseases ; Life Sciences ; Mathematical models ; Rapid Communication ; Santé publique et épidémiologie ; SARS-CoV-2 ; Seasons ; Vaccination</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-01, Vol.27 (1)</ispartof><rights>Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Jan 6, 2022</rights><rights>Attribution</rights><rights>This article is copyright of the authors or their affiliated institutions, 2022. 2022 The authors or their affiliated institutions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3</citedby><cites>FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3</cites><orcidid>0000-0001-9186-4549 ; 0000-0002-3542-7245 ; 0000-0003-0563-8428</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739339/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739339/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34991778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.sorbonne-universite.fr/hal-03518970$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bosetti, Paolo</creatorcontrib><creatorcontrib>Tran Kiem, Cécile</creatorcontrib><creatorcontrib>Andronico, Alessio</creatorcontrib><creatorcontrib>Paireau, Juliette</creatorcontrib><creatorcontrib>Levy-Bruhl, Daniel</creatorcontrib><creatorcontrib>Alter, Lise</creatorcontrib><creatorcontrib>Fontanet, Arnaud</creatorcontrib><creatorcontrib>Cauchemez, Simon</creatorcontrib><title>Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisation peak by 25%, 36% and 43% respectively, with a delay of 5 months between second and third dose. A 10% reduction in transmission rates might further reduce it by 41%, indicating that even small increases in protective behaviours may be critical to mitigate the wave.</description><subject>COVID-19</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration & dosage</subject><subject>Disease control</subject><subject>France - epidemiology</subject><subject>Hospitalization</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Immunity (Disease)</subject><subject>Immunization, Secondary</subject><subject>Infectious diseases</subject><subject>Life Sciences</subject><subject>Mathematical models</subject><subject>Rapid Communication</subject><subject>Santé publique et épidémiologie</subject><subject>SARS-CoV-2</subject><subject>Seasons</subject><subject>Vaccination</subject><issn>1560-7917</issn><issn>1025-496X</issn><issn>1560-7917</issn><issn>1025-496X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdUl1v0zAUtRCIjcJfQJaQEDwku77Ol3lAmrqOVaq0hwGvlmuc1VNih8Rp2d_gF-PQ0o1Jlmxdn3Pu1yHkPYMUKyjPWF5AUgpWpoubFAExxTJlKTJgDPNn5PQIeP7ofUJeDcMdQMZB4EtywjMRo2V1Sn4v207pQH1N194PwfR0q7S2TgXrHY0nbAzV3oXeNxNqfv19eZEwQS9MExTdqa2h9gFlfv3V2iln3S21bTs6G-4_UdV1jdV70eDpZa-cPhJ31k2JYzvsDPE1eVGrZjBvDveMfLtcfJ1fJavrL8v5-SrROUBIBIqszrk2WPAC1pVgBn5ow7MamcgVL2oNOUeEsjZFkWGt1qwuAIwoMBOl4TPyea_bjevWRGrsUTWy622r-nvplZX__zi7kbd-K6uSCx7PjHzcC2ye0K7OV3KKAc9ZJUrYsoj9cEjW-5-jGYJs7aBN0yhn_DhILFiFHOIEIvTdE-idH3sXRxFRCBB3yLOH6nXvh6E39bECBnKyipy2L6fty8WNnKwiMQblwSpR4O3j9o_0f97gfwCCAblG</recordid><startdate>20220106</startdate><enddate>20220106</enddate><creator>Bosetti, Paolo</creator><creator>Tran Kiem, Cécile</creator><creator>Andronico, Alessio</creator><creator>Paireau, Juliette</creator><creator>Levy-Bruhl, Daniel</creator><creator>Alter, Lise</creator><creator>Fontanet, Arnaud</creator><creator>Cauchemez, Simon</creator><general>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</general><general>European Centre for Disease Prevention and Control</general><general>European Centre for Disease Prevention and Control (ECDC)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9186-4549</orcidid><orcidid>https://orcid.org/0000-0002-3542-7245</orcidid><orcidid>https://orcid.org/0000-0003-0563-8428</orcidid></search><sort><creationdate>20220106</creationdate><title>Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22</title><author>Bosetti, Paolo ; Tran Kiem, Cécile ; Andronico, Alessio ; Paireau, Juliette ; Levy-Bruhl, Daniel ; Alter, Lise ; Fontanet, Arnaud ; Cauchemez, Simon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>COVID-19</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration & dosage</topic><topic>Disease control</topic><topic>France - epidemiology</topic><topic>Hospitalization</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Immunity (Disease)</topic><topic>Immunization, Secondary</topic><topic>Infectious diseases</topic><topic>Life Sciences</topic><topic>Mathematical models</topic><topic>Rapid Communication</topic><topic>Santé publique et épidémiologie</topic><topic>SARS-CoV-2</topic><topic>Seasons</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bosetti, Paolo</creatorcontrib><creatorcontrib>Tran Kiem, Cécile</creatorcontrib><creatorcontrib>Andronico, Alessio</creatorcontrib><creatorcontrib>Paireau, Juliette</creatorcontrib><creatorcontrib>Levy-Bruhl, Daniel</creatorcontrib><creatorcontrib>Alter, Lise</creatorcontrib><creatorcontrib>Fontanet, Arnaud</creatorcontrib><creatorcontrib>Cauchemez, Simon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bosetti, Paolo</au><au>Tran Kiem, Cécile</au><au>Andronico, Alessio</au><au>Paireau, Juliette</au><au>Levy-Bruhl, Daniel</au><au>Alter, Lise</au><au>Fontanet, Arnaud</au><au>Cauchemez, Simon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2022-01-06</date><risdate>2022</risdate><volume>27</volume><issue>1</issue><issn>1560-7917</issn><issn>1025-496X</issn><eissn>1560-7917</eissn><eissn>1025-496X</eissn><abstract>Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 65, ≥ 50 or ≥ 18 year-olds may reduce the hospitalisation peak by 25%, 36% and 43% respectively, with a delay of 5 months between second and third dose. A 10% reduction in transmission rates might further reduce it by 41%, indicating that even small increases in protective behaviours may be critical to mitigate the wave.</abstract><cop>Sweden</cop><pub>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</pub><pmid>34991778</pmid><doi>10.2807/1560-7917.ES.2022.27.1.2101125</doi><orcidid>https://orcid.org/0000-0001-9186-4549</orcidid><orcidid>https://orcid.org/0000-0002-3542-7245</orcidid><orcidid>https://orcid.org/0000-0003-0563-8428</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1560-7917
ispartof	Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-01, Vol.27 (1)
issn	1560-7917 1025-496X 1560-7917 1025-496X
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8739339
source	PubMed Central
subjects	COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage Disease control France - epidemiology Hospitalization Human health and pathology Humans Immunity (Disease) Immunization, Secondary Infectious diseases Life Sciences Mathematical models Rapid Communication Santé publique et épidémiologie SARS-CoV-2 Seasons Vaccination
title	Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A22%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20booster%20vaccination%20on%20the%20control%20of%20COVID-19%20Delta%20wave%20in%20the%20context%20of%20waning%20immunity:%20application%20to%20France%20in%20the%20winter%202021/22&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Bosetti,%20Paolo&rft.date=2022-01-06&rft.volume=27&rft.issue=1&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/1560-7917.ES.2022.27.1.2101125&rft_dat=%3Cproquest_pubme%3E2618230021%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-9294f53ce26360b891e0dce34f2195a36fc0532207fe6642fab1f600e962497e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620030934&rft_id=info:pmid/34991778&rfr_iscdi=true